Barbara Jane Dillon

2.0k total citations
24 papers, 1.6k citations indexed

About

Barbara Jane Dillon is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Barbara Jane Dillon has authored 24 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 10 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Barbara Jane Dillon's work include Tuberculosis Research and Epidemiology (12 papers), Bacillus and Francisella bacterial research (7 papers) and Immune responses and vaccinations (6 papers). Barbara Jane Dillon is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Bacillus and Francisella bacterial research (7 papers) and Immune responses and vaccinations (6 papers). Barbara Jane Dillon collaborates with scholars based in United States, China and Finland. Barbara Jane Dillon's co-authors include Marcus A. Horwitz, Saša Masleša-Galić, Günter Harth, G Harth, Bai‐Yu Lee, Daniel L. Clemens, Jeffrey I. Zink, Zilu Li, Angela Hwang and Qingmei Jia and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Barbara Jane Dillon

24 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Jane Dillon United States	16	921	586	530	425	139	24	1.6k
Gucheng Zeng China	28	801 0.9×	1.0k 1.8×	583 1.1×	774 1.8×	57 0.4×	61	2.4k
Laura E. Ruff United States	15	604 0.7×	1.7k 3.0×	635 1.2×	429 1.0×	44 0.3×	22	2.8k
Vania Manolova Switzerland	16	213 0.2×	1.1k 1.9×	243 0.5×	738 1.7×	127 0.9×	33	2.2k
Mary C. Graves United States	18	431 0.5×	437 0.7×	294 0.6×	935 2.2×	96 0.7×	33	2.2k
Theodora Fifis Australia	18	494 0.5×	568 1.0×	474 0.9×	629 1.5×	65 0.5×	38	1.5k
Chengyao Li China	24	334 0.4×	218 0.4×	846 1.6×	344 0.8×	54 0.4×	124	1.8k
Zheng W. Chen United States	40	1.4k 1.5×	2.5k 4.3×	1.1k 2.2×	1.0k 2.4×	142 1.0×	116	4.4k
Rene Alvarez United States	20	677 0.7×	288 0.5×	1.2k 2.3×	1.1k 2.5×	121 0.9×	30	2.5k
Qiu Zhong China	22	275 0.3×	332 0.6×	474 0.9×	609 1.4×	25 0.2×	76	1.8k
Caroline J. Barelle United Kingdom	20	731 0.8×	290 0.5×	577 1.1×	929 2.2×	55 0.4×	42	1.8k

Countries citing papers authored by Barbara Jane Dillon

Since Specialization

Citations

This map shows the geographic impact of Barbara Jane Dillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Jane Dillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Jane Dillon more than expected).

Fields of papers citing papers by Barbara Jane Dillon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Jane Dillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Jane Dillon. The network helps show where Barbara Jane Dillon may publish in the future.

Co-authorship network of co-authors of Barbara Jane Dillon

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Jane Dillon. A scholar is included among the top collaborators of Barbara Jane Dillon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Jane Dillon. Barbara Jane Dillon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Palermo, Amelia, Shen Li, Johanna ten Hoeve, et al.. (2023). A ketogenic diet can mitigate SARS-CoV-2 induced systemic reprogramming and inflammation. Communications Biology. 6(1). 1115–1115. 6 indexed citations

Clemens, Daniel L., Bai‐Yu Lee, Aleidy Silva, et al.. (2019). Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs. PLoS ONE. 14(5). e0215607–e0215607. 22 indexed citations

Lee, Bai‐Yu, Daniel L. Clemens, Aleidy Silva, et al.. (2018). Ultra-rapid near universal TB drug regimen identified via parabolic response surface platform cures mice of both conventional and high susceptibility. PLoS ONE. 13(11). e0207469–e0207469. 14 indexed citations

Jia, Qingmei, et al.. (2018). Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia. Scientific Reports. 8(1). 7009–7009. 14 indexed citations

Lee, Bai‐Yu, Daniel L. Clemens, Aleidy Silva, et al.. (2017). Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time. Nature Communications. 8(1). 14183–14183. 45 indexed citations

Jia, Qingmei, Barbara Jane Dillon, Saša Masleša-Galić, & Marcus A. Horwitz. (2017). Listeria-Vectored Vaccine Expressing the Mycobacterium tuberculosis 30-Kilodalton Major Secretory Protein via the Constitutively Active prfA * Regulon Boosts Mycobacterium bovis BCG Efficacy against Tuberculosis. Infection and Immunity. 85(9). 12 indexed citations

Stefanova, D, João Arezes, Piotr Ruchała, et al.. (2017). Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non–transferrin-bound iron. Blood. 130(3). 245–257. 109 indexed citations

Cunningham, Cameron R., Ameya S. Champhekar, Michael V. Tullius, et al.. (2016). Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence. PLoS Pathogens. 12(1). e1005356–e1005356. 54 indexed citations

Jia, Qingmei, Richard A. Bowen, Bai‐Yu Lee, et al.. (2016). Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge. Vaccine. 34(41). 4969–4978. 14 indexed citations

10.

Lee, Bai‐Yu, Zilu Li, Daniel L. Clemens, et al.. (2016). Redox‐Triggered Release of Moxifloxacin from Mesoporous Silica Nanoparticles Functionalized with Disulfide Snap‐Tops Enhances Efficacy Against Pneumonic Tularemia in Mice. Small. 12(27). 3690–3702. 72 indexed citations

11.

Li, Zilu, Daniel L. Clemens, Bai‐Yu Lee, et al.. (2015). Mesoporous Silica Nanoparticles with pH-Sensitive Nanovalves for Delivery of Moxifloxacin Provide Improved Treatment of Lethal Pneumonic Tularemia. ACS Nano. 9(11). 10778–10789. 107 indexed citations

12.

Hwang, Angela, Bai‐Yu Lee, Daniel L. Clemens, et al.. (2015). pH‐Responsive Isoniazid‐Loaded Nanoparticles Markedly Improve Tuberculosis Treatment in Mice. Small. 11(38). 5066–5078. 68 indexed citations

13.

Jia, Qingmei, et al.. (2013). A Heterologous Prime-Boost Vaccination Strategy Comprising the Francisella tularensis Live Vaccine StraincapBMutant and Recombinant Attenuated Listeria monocytogenes Expressing F. tularensis IglC Induces Potent Protective Immunity in Mice against Virulent F. tularensis Aerosol Challenge. Infection and Immunity. 81(5). 1550–1561. 23 indexed citations

14.

Jia, Qingmei, et al.. (2010). A Francisella tularensis Live Vaccine Strain (LVS) Mutant with a Deletion in capB , Encoding a Putative Capsular Biosynthesis Protein, Is Significantly More Attenuated than LVS yet Induces Potent Protective Immunity in Mice against F. tularensis Challenge. Infection and Immunity. 78(10). 4341–4355. 46 indexed citations

15.

Horwitz, Marcus A., Günter Harth, Barbara Jane Dillon, & Saša Masleša-Galić. (2008). Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis. Vaccine. 27(3). 441–445. 37 indexed citations

16.

Tullius, Michael V., Günter Harth, Saša Masleša-Galić, Barbara Jane Dillon, & Marcus A. Horwitz. (2008). A Replication-Limited Recombinant Mycobacterium bovis BCG Vaccine against Tuberculosis Designed for Human Immunodeficiency Virus-Positive Persons Is Safer and More Efficacious than BCG. Infection and Immunity. 76(11). 5200–5214. 63 indexed citations

17.

Horwitz, Marcus A., G Harth, Barbara Jane Dillon, & Saša Masleša-Galić. (2005). A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG. Vaccine. 24(10). 1593–1600. 35 indexed citations

18.

Horwitz, Marcus A., Günter Harth, Barbara Jane Dillon, & Saša Masleša-Galić. (2005). Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity. Vaccine. 24(4). 443–451. 24 indexed citations

19.

Horwitz, Marcus A., Günter Harth, Barbara Jane Dillon, & Saša Masleša-Galić. (2000). Recombinant bacillus Calmette–Guérin (BCG) vaccines expressing theMycobacterium tuberculosis30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proceedings of the National Academy of Sciences. 97(25). 13853–13858. 354 indexed citations

20.

Horwitz, Marcus A., et al.. (1995). Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis.. Proceedings of the National Academy of Sciences. 92(5). 1530–1534. 379 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact